Leidos Donates $2.5 Million to The Children's Inn at NIH to Expand Support for Pediatric Research
Leidos (NYSE: LDOS) has announced a $2.5 million donation to The Children's Inn at the National Institutes of Health (NIH). The contribution will support renovations and expansions to increase capacity for serving young patients and families participating in pediatric research. The donation is part of The Children's Inn's $50 million Building Extraordinary capital campaign, which aims to enhance facilities and services. Upon completion in 2027, the expansion will increase capacity by 25%, allowing accommodation for up to 3,000 patients annually. The Inn's new porte-cochère will bear the Leidos name in recognition of this gift.
Leidos (NYSE: LDOS) ha annunciato una a The Children's Inn presso il National Institutes of Health (NIH). Il contributo sosterrà i lavori di ristrutturazione e ampliamento per aumentare la capacità di assistenza ai giovani pazienti e alle famiglie coinvolte nella ricerca pediatrica. La donazione fa parte della campagna Building Extraordinary da 50 milioni di dollari di The Children's Inn, che mira a migliorare le strutture e i servizi. Al termine dei lavori nel 2027, l'ampliamento aumenterà la capacità del 25%, consentendo l'alloggiamento di fino a 3.000 pazienti all'anno. Il nuovo porte-cochère dell'Inn porterà il nome di Leidos in riconoscimento di questo regalo.
Leidos (NYSE: LDOS) ha anunciado una para The Children's Inn en los Institutos Nacionales de Salud (NIH). La contribución apoyará las renovaciones y expansiones para aumentar la capacidad de atención a pacientes jóvenes y sus familias que participan en la investigación pediátrica. La donación es parte de la campaña de capital Building Extraordinary de 50 millones de dólares de The Children's Inn, que tiene como objetivo mejorar las instalaciones y los servicios. Al finalizar en 2027, la expansión aumentará la capacidad en un 25%, permitiendo el alojamiento de hasta 3,000 pacientes anualmente. El nuevo porte-cochère del Inn llevará el nombre de Leidos en reconocimiento a este regalo.
Leidos (NYSE: LDOS)는 250만 달러의 기부를 NIH(국립 보건원)의 The Children's Inn에 발표했습니다. 이 기부금은 소아 연구에 참여하는 어린 환자와 가족들을 위한 수용 능력 증대를 위해 리모델링과 확장을 지원할 것입니다. 이 기부는 The Children's Inn의 5000만 달러 규모의 Building Extraordinary 자본 캠페인의 일환으로, 시설과 서비스를 개선하는 것을 목표로 하고 있습니다. 2027년에 완공되면, 확장은 25%의 수용능력 증가를 가져와 연간 최대 3,000명의 환자를 수용할 수 있게 됩니다. Inn의 새로운 포르테코체는 이 기부에 대한 감사의 표시로 Leidos라는 이름을 붙일 것입니다.
Leidos (NYSE: LDOS) a annoncé un donnement de 2,5 millions de dollars à The Children's Inn des National Institutes of Health (NIH). Cette contribution soutiendra des rénovations et des extensions pour augmenter la capacité d'accueil des jeunes patients et des familles participant à la recherche pédiatrique. Le don s'inscrit dans le cadre de la campagne de capital Building Extraordinary de 50 millions de dollars de The Children's Inn, qui vise à améliorer les installations et les services. Lors de l'achèvement en 2027, l'extension augmentera la capacité de 25%, permettant l'hébergement de jusqu'à 3.000 patients par an. Le nouveau porte-cochère de l'Inn portera le nom de Leidos en reconnaissance de ce don.
Leidos (NYSE: LDOS) hat eine Spendensumme von 2,5 Millionen Dollar für The Children's Inn an den National Institutes of Health (NIH) angekündigt. Der Beitrag wird Renovierungen und Erweiterungen unterstützen, um die Kapazität für die Betreuung junger Patienten und Familien, die an der pädiatrischen Forschung teilnehmen, zu erhöhen. Die Spende ist Teil der 50 Millionen Dollar teuren Building Extraordinary-Kapitalaktion von The Children's Inn, die darauf abzielt, die Einrichtungen und Dienstleistungen zu verbessern. Nach Abschluss im 2027 wird die Erweiterung die Kapazität um 25% erhöhen und so Platz für bis zu 3.000 Patienten jährlich schaffen. Der neue Porte-cochère des Inns wird den Namen Leidos tragen, um sich für dieses Geschenk zu bedanken.
- None.
- None.
Insights
The
This partnership with the NIH Clinical Center positions Leidos strategically in the rare disease research ecosystem, where approximately 1,500 active protocols are being conducted. The expansion project's goal to increase capacity by
"For more than two decades, Leidos has stood alongside The Children's Inn, championing its mission to create a place like home for children and families fighting rare and complex diseases," said Leidos CEO, Tom Bell. "This donation reflects our deep commitment to advancing medical research and supporting the courageous families who inspire us every day."
The gift supports The Children's Inn's
"As a company dedicated to delivering innovative health solutions, we are honored to deepen our partnership with The Children's Inn," said Liz Porter, Leidos Health & Civil Sector president. "This transformative project strengthens essential support for families while driving the advancement of life-changing medical discoveries."
The donation underscores Leidos' mission-driven focus on advancing health and clinical research in collaboration with the
"Leidos has been a fundamental pillar of support for The Children's Inn for more than 20 years, and its ongoing support has made an indelible impact on the lives of countless families," said The Inn's CEO Jennie Lucca. "This donation will help bring our vision for The Inn of Tomorrow to life, providing an even more welcoming and supportive environment for children and families who come to the NIH for life-saving treatments. Leidos' generosity is a testament to its belief in the power of innovation and compassion to change lives."
This donation builds on Leidos' recent contributions to Drake State Community & Technical College and
About Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in
About The Children's Inn
The Children's Inn at NIH is a private, nonprofit "Place Like Home" for children and their families participating in pediatric research at the National Institutes of Health Clinical Center, the world's premier biomedical research hospital. The Inn reduces the burden of illness through therapeutic, educational, and recreational programming at no cost to families. Since opening in 1990, more than 16,000 families from around the world and all 50 states have made The Inn their home during clinical trials. As a partner in discovery and care with the NIH, The Inn strives for the day when no family endures the heartbreak of a seriously ill child.
The NIH Clinical Center is at the forefront of a new era of promising pediatric research. As the world leader in rare disease research, the NIH is positioned to make significant breakthroughs in treating rare inherited diseases, most of which continue to lack a safe, effective treatment. The Clinical Center has about 1,500 active protocols, one-third of which include children. Propelled by advances in gene therapy and cellular engineering, NIH researchers anticipate advanced treatments and even cures for some rare genetic diseases on the horizon.
Contact:
Alyssa Pettus
(571) 992-5499
alyssa.t.pettus@leidos.com
Victor Melara
(703) 431-4612
victor.a.melara@leidos.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/leidos-donates-2-5-million-to-the-childrens-inn-at-nih-to-expand-support-for-pediatric-research-302328976.html
SOURCE Leidos
FAQ
How much did Leidos (LDOS) donate to The Children's Inn at NIH in December 2023?
What is the expected capacity increase at The Children's Inn following LDOS's donation?
What is the total value of The Children's Inn's Building Extraordinary capital campaign that LDOS is supporting?
How will Leidos (LDOS) be recognized for their donation to The Children's Inn?
